Several studies including murine models have revealed a link between oncogenic KRAS [11,12,13,14] and EGFR [15,16,17] and increased canonical NF-κB activity in mouse lung cancer models and human lung epithelial cells, and the induction of an inflammatory response in lung tumours. The gene discussed is KRAS; the disease is lung carcinoma.